The Sleeper Health Cost Policy July 22, 2021 Perspective In this Axios column, Drew Altman unpacks President Biden’s recent executive order on promoting competition, exploring its significance for new efforts to control health costs by addressing consolidation in the health care industry.
Why Drug Price Negotiation Has Staying Power June 25, 2021 Perspective In this Axios column, Drew Altman looks beyond Medicare to what’s at stake for employers and workers in the debate about the government negotiating drug prices.
Expanding Medicare to Adults at Age 60 Years—Medicare-for-More? May 27, 2021 Perspective In this column for the JAMA Health Forum, Larry Levitt examines the implications of lowering Medicare’s age of eligibility, which is emerging as a potential pathway toward Medicare-for-all or a public option among single-payer advocates. He explores the implications for costs, industry, people and broader reform efforts.
Persistent Vaccine Myths May 26, 2021 Perspective With news that the country has now vaccinated half of its population with at least one dose, This Drew Altman Axios column highlights the persistent COVID-19 vaccine myths that are believed by a substantial portion of the unvaccinated population and discusses the options to address vaccine misinformation.
We aren’t getting a national vaccine ‘passport.’ So let’s use the next best thing: CDC vaccination cards. May 25, 2021 Perspective In this op-ed for The Washington Post, Drew Altman suggests a way out of the heated debate about a COVID-19 vaccination passport to help provide clarity about who is vaccinated and who still ought to wear masks in public spaces or the workplace by using something that already exists– CDC vaccination cards.
Corporate Leaders Are Getting Bullish On Government Action On Health Care Costs April 29, 2021 Perspective In this Axios column, Drew Altman explores whether the long struggle with rising health costs has caused the tide to turn in corporate leaders’ attitudes towards government involvement in controlling health spending and whether it is part of a larger shift in comfort with government action to solve problems.
Why Doctors and Nurses Can Be Vital Vaccine Messengers April 5, 2021 Perspective In this Axios column, Drew Altman examines why doctors and nurses are such critical messengers in the effort to build vaccine confidence.
Dysfunctional websites are making it harder for Americans to get vaccinated. Here’s how to fix that. March 31, 2021 Perspective In an op-ed for The Washington Post, Drew Altman spells out how COVID-19 vaccination can be simplified to ensure that the public’s rising confidence in the vaccine isn’t thwarted by frustrating and sometimes dysfunctional websites.
Where To Start To Build Vaccine Confidence March 22, 2021 Perspective In this Axios column Drew Altman writes about the recent attention to Republican vaccine resisters. “Republicans and rural Americans are among the most resistant vaccine holdouts and some strategies are emerging to reach them.” But “far from all Republicans are resisters” and “the bigger and quicker payoff will come from prioritizing the more moveable group of ‘wait and see’ Americans.”
Vaccine Confidence Isn’t The Main Obstacle To Reaching Herd Immunity March 1, 2021 Perspective In this Axios column, Drew Altman paints a more optimistic picture of the prospects for getting to herd immunity as vaccine confidence grows, but underscores the urgency of building vaccine confidence in Black and Latino communities where barriers to access and good information are obstacles to getting vaccinated.
